SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001169245-22-000037
Filing Date
2022-04-22
Accepted
2022-04-22 16:13:54
Documents
5
Period of Report
2022-04-22

Document Format Files

Seq Description Document Type Size
1 DEFA14A proxy2022.htm DEF 14A 464414
2 phasebio2020logoa.jpg GRAPHIC 27705
3 phasebio2020proxystat_imaga.gif GRAPHIC 3535
4 proxycardpg1a.jpg GRAPHIC 97626
5 proxycardpg2a.jpg GRAPHIC 49178
  Complete submission text file 0001169245-22-000037.txt   700563
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38697 | Film No.: 22845669
SIC: 2834 Pharmaceutical Preparations